"Vilprafen 1000": ntuziaka, analogues, reviews

Gịnị bụ ọgwụ "Vilprafen 1000"? Azịza nke mgbagwoju anya ọgwụ nke ị ga-ahụ na ihe ndị ahụ ndị na-esonụ. Ọzọkwa si na ya, ị ga-amụta banyere otú na-ọgwụ, ihe ọ pụtara, ma n'akụkụ mmetụta na contraindications bụ karịa na ọ ga-anọchi, na na.

The mejupụtara nakwa ụdị nkwakọ a na ngwaọrụ ụlọọgwụ

Nkwadebe "Vilprafen 1000" nwere ike zụrụ na a na-ere ọgwụ na ụdị ọcha dispersible mbadamba (nwere ike ịbụ na a acha tinge). Ha nwere elongated udi na akara na okwu "na IOSA" na otu akụkụ, na "1000" nọmba nke ọzọ. Ọ kwesịkwara kwuru na ngwá ọrụ a nwere a ụtọ uto na okpukpo nke strawberries.

"Vilprafen 1000" ifịk ifịk ọgwụ umi na-josamycin. Dị ka ndị inyeaka mmiri, mgbe ahụ, ha na-agụnye aspartame, giproloza, colloidal sịlịkọn dioxide, microcrystalline cellulose, sodium docusate, strawberry flavor, na magnesium stearate.

Na ire nke ọgwụ abatakwa ọnya 5 mbadamba enịm ke a kaadiboodu igbe.

The pharmacological edinam nke ọgwụ

Gịnị bụ ọgwụ "Vilprafen 1000"? Ntuziaka maka ojiji nke a ọgwụ nwere ihe ọmụma banyere ihe na ngwá ọrụ bụ ọgwụ nje bụ ndị macrolide otu.

The usoro nke edinam nke ọgwụ n'okpuru echiche bụ ejikọrọ na ndị mebiri nke protein nsụchi sel nke ụmụ nje. Nke a na mmetụta bụ n'ihi na reversible adịgide adịgide nke nọ n'ọrụ umi si 50s-ribosomal subunit.

Na ọgwụgwọ ichekwa ngwá ọrụ bụ ike nke na-agbasi mgba ike a bacteriostatic mmetụta site slowing na mmeputakwa na uto nke bacteria. Ọ bụrụ na ị mepụtara na n'etiti mbufụt elu kasịnụ, ọ bụ ike bactericidal utịp.

The agwọ ọrịa "Vilprafen 1000" bụ ike karịsịa megide gram-nti na-gram-adịghị mma microorganisms. N'ihi ya, ọ na-adịghị emetụta enterobacteria. Na nke a, nkwadebe ghara imetụta ọnọdụ nke digestive tract microflora.

Mgbe ụfọdụ, ọgwụ na-anọgide n'ọrụ na iguzogide erythromycin na ndị ọzọ na macrolides.

Pharmacokinetics nke ọgwụ

ọgwụ ọjọọ, "Vilprafen 1000" Olee otú ogologo na-etinye obi gị dum? Eduzi ngwá ọrụ na-ekwu na mgbe onu ochichi nke nọ n'ọrụ mmewere nke ọgwụ nnọọ ngwa ngwa etinye obi gị dum na digestive tract. Na nri a na-emetụta bioavailability.

The kasị elu ịta nke a agwọ ọrịa enweta mgbe banyere onye hour mgbe ingestion. Na a onunu ogwu nke 1 g nke kacha ịta bụ banyere 2-3 mg / ml.

N'ọrụ umi bụ a agwọ ọrịa pụtara nke ọma na-ekesa na nsụkọrọ na esịtidem akụkụ (ma e wezụga na ụbụrụ). Na nke a, na ọgwụ na-arụpụta kasịnụ na gafere plasma ma echekwara na a ọgwụgwọ larịị maka a ogologo oge.

Josamycin elu kasịnụ hụrụ na tonsils, akpa ume, asu, adọka ọmụmụ na ajirija. The ọgwụ ngwa ngwa na-aga site na placental mgbochi na na-secreted na mmiri ara.

Josamycin (ifịk ọgwụ umi) na-metabolized na imeju. Nke a na-arụpụta n'ọrụ metabolites.

Nkwadebe ewepụtara predominantly na bile. Ma mkpochapu mmamịrị adịghị gafere 10%.

Egosi maka ojiji nke a na ngwaọrụ ụlọọgwụ

Mgbe m ga-eji ọgwụ ọjọọ, "Vilprafen 1000"? Nyocha banyere nke a agwọ ọrịa anyị ga-atụle mgbe e mesịrị. Ugbu a, m chọrọ ịgwa gị na nkà mmụta ọgwụ na-họpụtara naanị na na-efe efe na mkpali oria, nke e mere site microorganisms chebaara owuwu:

• diphtheria (dị ka ihe adjunct ọgwụ na diphtheria antitoxin);
• na-efe efe nke elu akụkụ okuku ume na tract na elu akụkụ okuku ume na tract (laryngitis, pharyngitis, otitis media, tonsillitis, Sinusitis na paratonzillite);
• ala akụkụ okuku ume na tract-efe efe (exacerbation nke ala ala bronchitis, nnukwu bronchitis, ka oyi baa);
• whooping ụkwara;
• uhie uhie fever (mgbe dị hypersensitivity na penicillin);
• na-efe efe nke na-edeghị ede oghere (pericoronitis, gingivitis, alveolitis, periodontitis, alveolar etuto);
• psittacosis;
• adụ anụ ahụ na-efe efe na akpụkpọ (furuncles, folliculitis, otutu, abrasions, lymphangitis, etuto, phlegmon, lymphadenitis, felon, ọnya, ọkụ, na post-ịwa ahụ na-efe efe);
• anya na-efe efe (dacryocystitis na blepharitis);
• erysipelas (mgbe dị hypersensitivity na penicillin);
• anthrax;
• Otutu na-efe efe, na urinary tract (cervicitis, urethritis, prostatitis, epididymitis);
• lymphogranuloma venereum ;
• ọrịa nke digestive usoro na na-metụtara Helicobacter pylori;
• syphilis na gonorrhea (ma ọ bụrụ na e nwere a hypersensitivity na penicillin).

Contraindications ojiji nke ọgwụ

Mgbe ụfọdụ, i nwere ike iji ọgwụ ọjọọ "Vilprafen Soljutab 1000"? Ọbịa ọkachamara na-ekwu na nke a ọgwụ ọjọọ nwere ndị na-esonụ contraindications:

• ụmụ obere ọmụmụ arọ (erughị 10 n'arọ);
• oké ọrịa imeju;
• Hypersensitivity na-arụsi ọrụ ike umi;
• Hypersensitivity na ogwu mgbochi ọgwụ ọjọọ nke na macrolide otu.

Drug "Vilprafen 1000": ntuziaka maka ojiji nke ọgwụ

The onunu ogwu nke ọgwụ kwesịrị ikpebisi ike naanị site ịga dibịa, na na na n'otu n'otu.

N'ihi na ndị okenye na-eto eto ihe karịrị afọ 14, ndị nkịtị olu nke ego bụ 1-2, o were ya na-atụ aro 2-3 awa. Ọ bụrụ na ọ dị mkpa, ndị dose nwere ike ụba (e.g., ruo 3 g kwa ụbọchị ahụ).

The kwa ụbọchị dose maka ụmụaka, onye ahu arọ bụ 10 n'arọ, na-kenyere dabeere na ngụkọta oge nke 40-50 mg kwa n'arọ ahu aro. Ikweta na ọgwụ dị mkpa na-ebu 2-3 ugboro n'ụbọchị.

Dabere na ndị e kwuru n'elu, ọ dị mfe iji gbakọọ na a na nwa na a arọ ahụ nke 10-20 n'arọ kwesịrị 250-500 mg nke ọgwụ ugboro abụọ n'ụbọchị (a nkeji iri na ise ma ọ bụ ọkara a mbadamba, tupu etisasịwo ke mmiri).

Child si 20-40 n'arọ ahu arọ nyere na 500-1000 mg ugboro abụọ n'ụbọchị (ma ọ bụ ọkara nke ihe dum mbadamba etisasịwo mmiri).

Children erikpu karịrị 40 n'arọ na-nyere 1000 mg (i.e., otu mbadamba) ugboro abụọ n'ụbọchị.

Otú ihe ị ga-ewere ọgwụ "Vilprafen" (1000 mg) Na oge nke ọgwụgwọ na ngwá ọrụ a na naanị kpebisiri ike site dọkịta (ọ bụ na-emekarị 5-21 ụbọchị, dabere na ogo na ọdịdị nke ọrịa).

Scheme Helicobacter ọgwụ (ọgwụgwọ nke gastric ọnyá)

Ugbu a, na ị maara otú e si lee "Vilprafen Soljutab 1000". Ọ bụrụ na ị chọrọ ọgwụ nke H. pylori, a ọgwụ na-ndinọ na a olu nke 1 g ugboro abụọ kwa ụbọchị maka 1-2 izu. Na nke a nkwadebe ga-achọkwa na ndị ọrụ ọzọ na ha ọkọlọtọ doses ( "Famotidine" "Omeprazole" "omez" "omez D" na na.).

Dispersible ọgwụ nwere ike iwere ọnụ ụzọ dị iche iche. Mbadamba na-loro dum (elu mmiri) ma ọ bụ tupu etisasịwo ke 20 ml nke mmiri. Na nke ikpeazụ ahụ, tupu n'ikuku ọ dị mkpa iji mix juputara na n'ihi nkwusioru.

Mmetụta mgbe iji ọgwụ

Analogs "Vilprafen 1000" na-akọkwara ọgwụ onwe ya nwere ike ime ka a ọnụ ọgụgụ nke ekwesighi Jeremaya mere. N'etiti mmetụta ọtụtụ ugboro ugboro hụrụ ndị dị ka ndị:

• Digestive tract: afo erughị ala, abdominal erughị ala, ọgbụgbọ, afọ ọsịsa, stomatitis, vomiting, afọ ntachi, pseudomembranous afọ, na -ebelata agụụ.
• Allergies: urticaria, anaphylactoid Jeremaya mere, erythema multiforme, angioedema, bullous dermatitis, Stevens-Johnson syndrome).
• Zhelchevyvodyashie ụzọ na imeju na jaundice, hepatic dysfunction.
• Uche ziri ezi: na-akwụsị akwụsị dose metụtara ntị impairment.
• Ndị ọzọ: purpura.

Mmekọrịta ọzọ ike n'aka

Ebe ọ bụ na bacteriostatic ọgwụ nje nwere ike belata antimicrobial edinam nke bactericidal ọgwụ nje, izere ha nkwonkwo ngwa.

Josamycin a machibidoro kpam kpam ekenye ọnụ na lincosamides. Nke a bụ n'ihi na eziokwu na ọ bụ omume a ibe Mbelata ha arụmọrụ.

Anọchitekwa anya nke macrolide budata akwụsịlata mkpochapu xanthine. Nke a nwere ike ime ka ihe mgbaàmà nke igbu egbu.

Mgbe e ji ọnụ, josamycin na Antihistamines nwere astemizole na terfenadine, nwere ike dịkwuo ize ndụ nke na-emepe emepe-eyi ndụ egwu arrhythmias.

E nwere akụkọ na ike nke vasoconstriction dị ka a n'ihi ihe ahụ na nkwonkwo eji ọgwụ nje si macrolide na ergot alkaloids.

Co-ochichi nke cyclosporine na josamycin akpata ihe na-abawanye na cyclosporine etoju ke ọbara na enwekwu ihe ize ndụ nke nephrotoxicity.

Ọ bụrụ na concomitant ojiji nke digoxin na josamycin pụrụ ịmụba larịị nke ọbara nke mbụ.

Special ntuziaka maka ojiji "Vilprafen 1000" ọgwụ

Na omume nke oké na persistent afọ ọsịsa kwesịrị iburu n'uche na likelihood nke na-emepe emepe a-eyi ndụ egwu pseudomembranous afọ (na ọrịa na-anata josamycin).

Na ọrịa na gbasara akụrụ odida ọgwụ na-atụ aro na-ewere n'ime akaụntụ ihe laabu ule.

Ọ dị mkpa ka a tụlee likelihood nke cross-iguzogide dị iche iche na ọgwụ nje mmadụ bụ ndị ìgwè nke macrolides (bacteria na-eguzogide ọgwụ na ọgwụ nje, kọrọ, na chemical Ọdịdị, nwere ike ịbụ na-eguzogide ọgwụ ka josamycin).

Na-eri na analogues nke ọgwụ

Price atụle ọgwụ bụghị nnọọ elu. Ya mere, n'ihi na 10 mbadamba ọgwụ ị ga-akwụ banyere 150 Russian rubles. Kwere, nke a bụ a pụtara ala-na-eri, na-ewere n'ime akaụntụ irè nke ọgwụ ọjọọ, "Vilprafen 1000". Analogs dị ọnụ ala karịa ị na-eleghi anya na-ahụ na pharmacies.

Ọ bụrụ na ị na-atụle contraindicated ọgwụ, ọ ga-anọchi onye nke ndị na-esonụ ọgwụ: "midecamycin" "Roxithromycin", "Spiramycin", "Clarithromycin", "Azithromycin" ma ọ bụ "Erythromycin". Ndị a ọgwụ ọjọọ eme ihe ndị yiri ndị nke nọ n'ọrụ umi. The na-akpọ bughi analogs na a ọgwụ adịghị.

Nyocha nke ọrịa na ndị ọkachamara banyere ahụ ike na ihe owuwu

Taa, e nwere nnọọ ọtụtụ nke mma nzaghachi banyere nke a agwọ ọrịa. Ọrịa ndị na-ebi were ọgwụ, asị ya ngwa ngwa ọgwụgwọ mmetụta, nke anya na-ama mgbe mbụ dose. Nke a na-karịsịa hụrụ ndị dị otú ahụ abnormalities ka tonsillitis, otitis media, Sinusitis na cystitis.

Mmetụta mgbe na-ewere ọgwụ ọjọọ na-eme adịkarịghị. Ihe ndị ụfọdụ reviews na-ekwu banyere obi nkoropụ nke a oche, nakwa dị ka oge ọgbụgbọ. Site n'ụzọ, ndị a wetara mmetụta akwụsị spontaneously n'ime ụbọchị ole na ole.

Ọ kwesịkwara kwuru na a ọnụ ọgụgụ buru ibu nke ndị ọrịa mma na price nke ọgwụ.

Na nyochaa, ndị ọkachamara na-mara na o na ọgwụgwọ "Vilprafen" n'oge ime.